Zobrazeno 1 - 10
of 31
pro vyhledávání: '"F. Courrech"'
Autor:
J.F. Py, J. Salleron, G. Vogin, F. Courrech, P. Teixeira, S. Colnat-Coulbois, F. Baumard, S. Thureau, S. Supiot, D. Peiffert, G. Oldrini, J.C. Faivre
Publikováno v:
Cancer/Radiothérapie. 27:1-10
Autor:
Didier Peiffert, Guillaume Vogin, F. Courrech, J.-F. Py, Julia Salleron, A.S. Dietmann, V. Croisé-Laurent, Véronique Beckendorf
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 25(4)
Purpose To investigate clinical outcome and predicting factors of local failures in patients with colorectal cancer treated for unresectable liver metastases with stereotactic body radiation therapy (SBRT). Methods and materials We restrospectively r
Publikováno v:
Physica Medica. 68:39-40
Publikováno v:
Physica Medica. 68:47-48
Autor:
Jean Marc Constans, F. Courrech, Isabelle Behm-Ansmant, Guillaume Gauchotte, Guillaume Vogin, Anais Stefani, Julia Salleron, Liza Hettal
Publikováno v:
Radiation Research
Radiation Research, Radiation Research Society, 2020, 193 (5), pp.471. ⟨10.1667/RR15517.1⟩
Radiation Research, Radiation Research Society, 2020, 193 (5), pp.471. ⟨10.1667/RR15517.1⟩
Stereotactic radiotherapy (SRT) is recommended for treatment of brain oligometastasis (BoM) in patients with controlled primary disease. Where contrast enhancement enlargement occurs during follow-up, distinguishing between radionecrosis and progress
Publikováno v:
Physica Medica. 56:9-10
Introduction For small beams used in stereotactic radiotherapy, extra precautions need to be taken into account when determining dosimetric data used in the modelling of dose calculation algorithms [1] . In this work, we focused on the output factors
Autor:
F. Courrech, Julia Salleron, Didier Peiffert, Claire Charra-Brunaud, A. Huertas, Emilie Meknaci, J.P. Nesseler, Jean François Py, Sophie Renard-Oldrini
Publikováno v:
Brachytherapy. 16(5)
To evaluate the impact of bladder distension on doses to organs at risk in patients treated with 3D image-guided adaptive pulsed-dose-rate (PDR) brachytherapy (BT) for locally advanced cervical cancer.Twenty-two patients who had previously been treat
Autor:
J.-F. Py, E. Meknaci, Didier Peiffert, Julia Salleron, F. Courrech, S. Renard, C. Charra-Brunaud, M. Bruand
Publikováno v:
Cancer/Radiothérapie. 23:818
Introduction et but de l’etude Apres une mastectomie partielle, le traitement standard des cancers du sein localise est une irradiation mammaire totale. Des alternatives avec irradiation partielle acceleree du sein ont montre des resultats equivale
Autor:
Vincent Marchesi, F. Courrech, I. Buchheit, F. Baumard, L. Guinement, F. Saunier, Julia Salleron, K. Herlevin-Gérard
Publikováno v:
Physica Medica. 56:15
Introduction We conducted a practice analysis as part of a quality assurance process related to the commissioning of a Cyberknife M6. In this context, several physicists have been specifically trained. The purpose of this study was to assess whether
Autor:
Guillaume Oldrini, I. Buchheit, Sophie Renard-Oldrini, Didier Peiffert, F. Courrech, Guillaume Vogin, R. Jumeau
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 20(5)
Purpose Brachytherapy is a well-known treatment in the management of skin tumors. For facial or scalp lesions, applicators have been developed to deliver non-invasive treatment. We present cases treated with customized applicators with high dose rate